Loading clinical trials...
Loading clinical trials...
Post Marketing Surveillance Study For Observing Safety And Efficacy Of Lyrica
This study collects post-marketing safety and efficacy surveillance data in real world clinical use of pregabalin for its approved indications in Korea.
continuous patients with target disorders in collaborating institutions
Age
All ages
Sex
ALL
Healthy Volunteers
No
Start Date
July 1, 2006
Primary Completion Date
April 1, 2011
Completion Date
April 1, 2011
Last Updated
January 25, 2021
4,175
ACTUAL participants
pregabalin (Lyrica)
DRUG
pregabalin (Lyrica)
DRUG
pregabalin (Lyrica)
DRUG
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06726954